Novozymes A S DKK 2.0

13F holders, Q1 2025 (March 31)
2holders −1
0new positions
1sold out
$57.98avg. 13F price*

At the end of Q1 2025, 2 institutions reported holding Novozymes A S DKK 2.0 in their 13F filings, down 1 from Q4 2024. 0 opened new positions and 1 sold out. The largest holders were Somerville Kurt F ($1.2M) and Kidder Stephen W ($204K).

Company
Novozymes A S DKK 2.0
CUSIP
B798FW902
Latest filing quarter
Q2 2026

History

Number of 13F holders

012345 Q1 2024: 5Q1 2024Q2 2024: 5Q2 2024Q3 2024: 5Q3 2024Q4 2024: 3Q4 2024Q1 2025: 2Q1 2025Q2 2025: 3Q2 2025Q3 2025: 2Q3 2025Q4 2025: 3Q4 2025Q1 2026: 3Q1 2026Q2 2026: 4Q2 2026

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions0$0
Exits1$248K

All 13F filers, Q4 2024 → Q1 2025: 5,696 shares sold, net −5,696 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

Somerville Kurt F 0.21% Reduce -4.2% 20,390 $1.2M
Kidder Stephen W 0.06% Reduce -10.2% 3,525 $204K

"% of holder's portfolio" is NOVOZYMES A S DKK 2.0's weight in each manager's 13F, not the share of Novozymes A S DKK 2.0 the manager owns.